Tirzepatide
Tirzepatide is a pharmaceutical drug with 183 clinical trials. Currently 89 active trials ongoing. Historical success rate of 98.4%.
Success Metrics
Based on 62 completed trials
Phase Distribution
Phase Distribution
33
Early Stage
54
Mid Stage
71
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
93.9%
62 of 66 finished
6.1%
4 ended early
89
trials recruiting
183
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study to Evaluate ALN-2232 in Participants With Obesity
Tirzepatide to Reduce rEcurrence And Burden After Ablation of Atrial Fibrillation
Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors
A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)
Tirzepatide vs Semaglutide in Individuals at Cardiovascular Risk But Without Diabetes.
Clinical Trials (183)
A Study to Evaluate ALN-2232 in Participants With Obesity
Tirzepatide to Reduce rEcurrence And Burden After Ablation of Atrial Fibrillation
Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors
A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)
Tirzepatide vs Semaglutide in Individuals at Cardiovascular Risk But Without Diabetes.
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both
Tirzepatide on Atrial Fibrillation Recurrence After Catheter Ablation in Patients With Obesity and HFpEF
The Effect of Tirzepatide on Menopausal Vasomotor Symptoms and Biological Aging in Post-menopausal Women With Obesity
Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Resistance Exercise and Incretin Mimetic for Cardiometabolic Health in Survivors of ALL With Obesity
Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer
A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
GLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Pilot Trial
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
GLP-1R Actions on Muscle and the Skeleton
Effects of Tirzepatide on Blood, Imaging and Breast Tissue Biomarkers
A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood Sugar
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 183